Clinical Trial Update: Phase I Study to Evaluate a Human Monoclonal Antibody (MAb) 10E8VLS Administered Alone or Concurrently With MAb VRC07-523LS Via Subcutaneous Injection in Healthy Adults [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating a human monoclonal antibody 10E8VLS alone or with VRC07-523LS in healthy adults has been terminated; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Healthy Adult Immune Response

Drugs mentioned

• MAb 10E8VLS (10E8VLS)
• MAb VRC07-523LS (VRC07-523LS)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Healthy Adult Immune Response | Phase 1 | Status: TERMINATED | Results posted: 2020-12-30